We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States o... ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United States of America. Show more
IPA (IMMUNOPRECISE ANTIBODIES LTD) (la « Société » ou « IPA») (NASDAQ : IPA), InterSystems , un fournisseur créatif de technologies de données qui aide les clients à résoudre leurs défis les plus...
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability...
Un débit important de LSA pour faire progresser le développement de médicaments axé sur la diversité et les données d'IPA et pour enrichir LENSai™. IPA (IMMUNOPRECISE ANTIBODIES LTD.) (la «...
Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENSai™. IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an...
IPA annonce un quatrième trimestre consécutif de hausse des revenus IPA (IMMUNOPRECISE ANTIBODIES LTD.) (la « société » ou « IPA ») (NASDAQ : IPA), une entreprise de recherche et de technologie...
IPA reports a fourth consecutive quarter of increased revenue. IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic...
Dirk Van Hyfte, MD, PhD, cofondateur et responsable de l'innovation de BioStrand, présentera ces conclusions la semaine prochaine à la conférence HIMSS24 à Orlando, Floride IPA (IMMUNOPRECISE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -7.35294117647 | 1.36 | 1.39 | 1.17 | 98604 | 1.27626541 | CS |
4 | -0.16 | -11.2676056338 | 1.42 | 1.64 | 1.17 | 116248 | 1.44497966 | CS |
12 | -0.27 | -17.6470588235 | 1.53 | 2.6 | 1.17 | 635097 | 1.80327286 | CS |
26 | 0.01 | 0.8 | 1.25 | 2.6 | 0.94 | 354149 | 1.74469804 | CS |
52 | -1.38 | -52.2727272727 | 2.64 | 4.22 | 0.94 | 208343 | 1.92502486 | CS |
156 | -8.76 | -87.4251497006 | 10.02 | 16.47 | 0.94 | 286334 | 9.24196931 | CS |
260 | -20.74 | -94.2727272727 | 22 | 33.34 | 0.94 | 270683 | 9.41216152 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions